1. Home
  2. RVPH vs GLE Comparison

RVPH vs GLE Comparison

Compare RVPH & GLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • GLE
  • Stock Information
  • Founded
  • RVPH 2006
  • GLE 2018
  • Country
  • RVPH United States
  • GLE Hong Kong
  • Employees
  • RVPH N/A
  • GLE N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • GLE
  • Sector
  • RVPH Health Care
  • GLE
  • Exchange
  • RVPH Nasdaq
  • GLE NYSE
  • Market Cap
  • RVPH 88.0M
  • GLE 82.3M
  • IPO Year
  • RVPH N/A
  • GLE 2024
  • Fundamental
  • Price
  • RVPH $2.09
  • GLE $1.58
  • Analyst Decision
  • RVPH Strong Buy
  • GLE
  • Analyst Count
  • RVPH 5
  • GLE 0
  • Target Price
  • RVPH $11.40
  • GLE N/A
  • AVG Volume (30 Days)
  • RVPH 1.8M
  • GLE 143.7K
  • Earning Date
  • RVPH 11-14-2024
  • GLE 11-01-2024
  • Dividend Yield
  • RVPH N/A
  • GLE N/A
  • EPS Growth
  • RVPH N/A
  • GLE N/A
  • EPS
  • RVPH N/A
  • GLE 0.02
  • Revenue
  • RVPH N/A
  • GLE $6,333,093.00
  • Revenue This Year
  • RVPH N/A
  • GLE N/A
  • Revenue Next Year
  • RVPH N/A
  • GLE N/A
  • P/E Ratio
  • RVPH N/A
  • GLE $86.16
  • Revenue Growth
  • RVPH N/A
  • GLE 10.67
  • 52 Week Low
  • RVPH $0.60
  • GLE $1.30
  • 52 Week High
  • RVPH $4.83
  • GLE $5.44
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 60.41
  • GLE N/A
  • Support Level
  • RVPH $1.78
  • GLE N/A
  • Resistance Level
  • RVPH $2.15
  • GLE N/A
  • Average True Range (ATR)
  • RVPH 0.15
  • GLE 0.00
  • MACD
  • RVPH 0.02
  • GLE 0.00
  • Stochastic Oscillator
  • RVPH 88.30
  • GLE 0.00

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About GLE GLOBAL ENGINE GROUP HOLDING LIMITED

Global Engine Group Holding Ltd offers integrated solutions by using ICT solutions to drive business outcomes and innovation. It serves primarily as a holding company for its operating subsidiary, Global Engine Limited. Its service offerings comprise services to telecom operators, including the one-stop shop purchase from telecom license application service to turnkey network setup as well as service outsourcing; business planning, development, technical and operations consulting programs structured to target the cloud computing and data center providers; system design, planning, development and operation services to technology companies; cloud platform deployment, IT system design and configuration services, maintenance services, data center colocation service and cloud service.

Share on Social Networks: